Hepatic immunology

Viral Hepatitis

Volumn , Issue , 2007, Pages 15-29

  O’Farrelly, Cliona ^a   Pierce, Robert H ^b   Crispe, Nicholas ^c  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Gross anatomy; Hepatic immunology; Hepatic lymph flow; Hepatic structure; Immunological environment

Indexed keywords

EID: 84889855261     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987131.ch2     Document Type: Chapter

References (158)

1. Arias IM. The Liver, Biology and Pathobiology, 4th edn. Philadelphia:Lippincott Williams & Wilkins, 2001.
2. Junqueira LC. Basic Histology, 6th edn. Norwalk: Appleton & Lange, 1989.
3. Guyton AC. Textbook of Medical Physiology, 10th edn. Philadelphia:WB Saunders, 2000.
4. Sternberg SS. Histology for Pathologists. New York: Raven Press, 1992.
5. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 1980;91:63-71.
6. Sahin S, Rowland M. Estimation of specific hepatic arterial water space. Am J Physiol 1998;275(2 Pt 1)):G228-36.
7. Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis 2001;31:125-50.
8. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 1970;31:125-50.
9. Martinez-Hernandez A. The hepatic extracellular matrix. II. Ontogenesis, regeneration and cirrhosis. Virchows Archiv Pathol Anat Histopathol 1993;423:77-84.
10. Motta P. The three-dimensional microanatomy of the liver. Arch Histol Jpn 1984;47:1-30.
11. Ohtani Y, Wang BJ, Poonkhum R, Ohtani O. Pathways for movement of fluid and cells from hepatic sinusoids to the portal lymphatic vessels and subcapsular region in rat livers. Arch Histol Cytol 2003;66:239-52.
12. Trutmann M, Sasse D. The lymphatics of the liver. Anat Embryol 1994;190:201-9.
13. Strey CW, Markiewski M, Mastellos D et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003;198:913-23.
14. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000;174:160-71.
15. Wagner S, Lynch NJ, Walter W, Schwaeble WJ, Loos M. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol 2003;170:1462-5.
16. Wisse E. Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope. J Ultrastruct Res 1974;46:499-520.
17. Wisse E. Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells. J Ultrastruct Res 1974;46:393-426.
18. Golden-Mason L, Curry M, Nolan N et al. Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor bearing adult human liver. Hepatology 2000;31:1251-6.
19. Naito M, Hasegawa G, Takahashi K. Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 1997;39:350-64.
20. Wardle EN. Kupffer cells and their function. Liver 1987;7:63-75.
21. Khansari N, Fudenberg HH. Immune elimination of autologous senescent erythrocytes by Kupffer cells in vivo. Cell Immunol 1983;80:426-30.
22. Hinglais N, Kazatchkine MD, Mandet C, Appay MD, Bariety J. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. Lab Invest 1989;61:509-14.
23. Ross GD, Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 1993;92:181-4.
24. Metley JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 1990;171:1753-71.
25. Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol 2003;21:177-204.
26. van Egmond M, van Garderen E, van Spriel AB et al. FcalphaRI- positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000;6:680-5.
27. Lentini A, Falasca L, Autuori F, Dini L. The simultaneous exposition of galactose and mannose-specific receptors on rat liver macrophages is developmentally regulated. Biosci Rep 1992;12:453-61.
28. van Oosten M, van Amersfoort ES, van Berkel TJ, Kuiper J. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res 2001;7:381-4.
29. Becker EL, Forouhar FA, Grunnet ML et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res 1998;292:129-35.
30. Hertzog PJ, O’Neill LA, Hamilton JA. The interferon in TLR signaling: more than just antiviral. Trends Immunol 2003;24:534-9.
31. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003;74:479-85.
32. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232-6.
33. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3:51-62.
34. Knolle PA, Loser E, Protzer et al. Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10. Clin Exp Immunol 1997;107:555-61.
35. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001;161:III-XIII, 1-151.
36. Matsuno K, Nomiyama H, Yoneyama H, Uwatoku R. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev Immunol 2002;9:143-9
37. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 2002;35:1093-103.
38. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001;99:201-10.
39. Uwatoku R, Suematsu M, Ezaki T et al. Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of Nacetylgalactosamine- specific sugar receptors. Gastroenterology 2001;121:1460-72.
40. Kudo S, Matsuno K, Ezaki T, Ogawa M. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids- lymph translocation. J Exp Med 1997;185:777-84.
41. Morita A, Itoh Y, Toyama T et al. Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice. Hepatol Res 2003;27:143-50.
42. Hayashi N, Matsui K, Tsutsui H et al. Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens. J Immunol 1999;163:6702-11.
43. Ramadori G, Dienes HP, Burger R, Meuer S, Rieder H, Meyer zum Buschenfelde KH. Expression of Ia-antigens on guinea pig Kupffer cells. Studies with monoclonal antibodies. J Hepatol 1986;2:208-17.
44. Rubinstein D, Roska AK, Lipsky PE Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogeneic T lymphocytes. J Immunol 1986;137:1803-10.
45. Lohse AW, Knolle PA, Bilo K et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996;110:1175-81.
46. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003;198:39-50.
47. Abbas AK and Lichtman AH. Cellular and Molecular Immunology, 5th edn. Saunders, Philadelphia 2003:88-90.
48. Janeway CA Jr, Medzhitov R. Innate immune regulation. Annu Rev Immunol 2002;20:197-216.
49. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-9.
50. Thomson AW, Drakes ML, Zahorchak AF et al. Hepatic dendritic cells: immunobiology and role in liver transplantation. J Leukoc Biol 1999;66:322-30.
51. Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 1999;68:1-8.
52. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999;20:27-32.
53. Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004;164:511-19.
54. Taniguchi T, Toyoshima T, Fukao K, Nakuchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996;2:198-203.
55. Watanabe H, Miyaji C, Seki S, Abo T. c-kit-stem cells and thymocyte precursors in the livers of adult mice. J Exp Med 1996;184: 687-93.
56. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty J, O’Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999;29:1193-8.
57. Cressman DE, Greenbaum LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-83.
58. Golden-Mason A, Kelly O, Traynor G et al. Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver: implications for extrathymic T cell development. Cytokine 2001;14:143-51.
59. Limmer A, Knolle PA. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch Immunol Ther Exp (Warsz) 2001;49(Suppl 1)):S7-S11.
60. Knolle PA, Limmer A. Control of immune responses by scavenger liver endothelial cells. Swiss Med Wkly 2003;133:501-6.
61. Knolle PA, Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 2001;22:432-7.
62. Limmer A, Ohl J, Kurts C et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000;6:1348-54.
63. Bertolino P, McCaughan GW, Bowen DG. Role of primary intrahepatic T-cell activation in the ‘liver tolerance effect’. Immunol Cell Biol 2002;80:84-92.
64. Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol 2003;21:29-70.
65. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999;284:825-9
66. Lichtman AH, Abbas AK. T-cell subsets: recruiting the right kind of help. Curr Biol 1997;7:R242-4.
67. Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002;298:1395-401.
68. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
69. Winnock M, Gacia Barcina M, Lukomska B et al. Human liverassociated lymphocytes: an overview. J Gastroenterol Hepatol 1995;10(Suppl 1)):S43-S46.
70. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000;174:47-62.
71. Huang L, Sye K, Crispe IN. Proliferation and apoptosis of B220+CD4-CD8-TCR alpha beta intermediate T cells in the liver of normal adult mice: implication for lpr pathogenesis. Int Immunol 1994;6:533-40.
72. Doherty DG, Norris S, Madrigal-Estebas L et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-21.
73. Rowell DL, Eckmann L, Dwinell MB et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol 1997;273(2 Pt 1)):G322-32.
74. Nuti S, Rosa D, Valiante NM et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998;28:3448-55.
75. Lalor P, Adams DH. The liver: a model of organ specific lymphocyte recruitment. Expert Rev Molec Med 2002 (02)00415-5a.pdf ISSN 1462-3994, Cambridge University Press.
76. Iigo Y, Suematsu M, Higashida T et al. Constitutive expression of ICAM-1 in rat microvascular systems analyzed by laser confocal microscopy. Am J Physiol 1997;273(1 Pt 2)):H138-47.
77. Van Oosten M, van de Bilt E, de Vries HE, van Berkel TJ, Kuiper J. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995;22:1538-46.
78. McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 1996;110:522-8.
79. Pardi R, Bender JR, Dettori C, Giannazza E, Engleman EG. Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol 1989;143:3157-66.
80. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999;163:3202-10.
81. Abuzakouk M, Kelleher D, Feighery C, O’Farrelly C. Increased HLA-DR and decreased CD3 on human intestinal intraepithelial lymphocytes: evidence of activation? Gut 1996;39:396-400.
82. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001;291:2413-17.
83. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001;410:101-5.
84. Wang XZ, Stepp SE, Brehm MA, Chen HD, Selin LK, Welsh RM. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity 2003;18:631-42.
85. Nagano H, Monden M, Gotoh M et al. Mechanisms involved in immunosuppression induced by intraportal injection of donor spleen cells in rats. Transplant Proc 1992;24:2900-1.
86. Qian S, Lu L, Fu F et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997;158:4654-61.
87. Belz GT, Altman JD, Doherty PC. Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA 1998;95:13812-17.
88. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-9.
89. Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D, Budd RC. Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens. J Exp Med 1998;188:1147-57.
90. Doherty DG, O’Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000;174:5-20.
91. Norris S, Collins C, Doherty DG et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998;28:84-90.
92. Kenna T, Golden-Mason L, Norris S, Hegarty JE, O’Farrelly C, Doherty DG. Distinct subpopulations of γδT cells are present in normal and tumor-bearing human liver. Clin Immunol 2004;113:56-63.
93. Hayday A, Theodoridis E, Ramsburg E, Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001;2:997-1003.
94. Havran EL. A role for epithelial γδT cells in tissue repair. Immunol Res 2000;21:63-9.
95. Carding SR, Egan PJ. γ/δT cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002;2:336.
96. Girardi M, Lewis J, Glusac E et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 2002;195:855-67.
97. Miller C, Roberts SJ, Ramsburg E, Hayday AC. gamma delta cells in gut infection, immunopathology, and organogenesis. Springer Semin Immunopathol 2000;22:297-310.
98. Moore TA, Moore BB, Newstead MW, Standiford TJ. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J Immunol 2000;165:2643-50.
99. Constant P, Poquet Y, Peyrat MA, Davodeau F, Bonneville M, Fournie JJ. The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human gamma delta T cells. Infect Immun 1995;63:4628-33.
100. Bukowski JF, Morita CT, Brenner MB. Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 1999;11:57-65.
101. Sciammas R, Tatsumi Y, Sperling AI, Arunan K, Bluestone JA. TCR gamma delta cells: mysterious cells of the immune system. Immunol Res 1994;13:268-79.
102. Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001;120:250-60.
103. Ohteki T, Abo T, Seki S et al. Predominant appearance of gamma/ delta T lymphocytes in the liver of mice after birth. Eur J Immunol 1991;21:1733-40.
104. Kodaira Y, Yokomuro K, Tanaka S, Miyazaki JI, Ikuta K. Developmental heterogeneity of V gamma 1.1 T cells in the mouse liver. Immunology 1996;87:213-19.
105. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδT cells. Science 1998;279:1737
106. Roark CE, Vollmer MK, Cambell PA, Born WK, O’Brien RL. Response of a gamma delta+ T cell receptor invariant subset during bacterial infection. J Immunol 1996;156:2214-20.
107. Hsieh B, Schrenzel MD, Mulvania T, Lepper HD, Di Molfetto-Landon L, Ferrick DA. In vivo cytokine production in murine listeriosis. Evidence for immunoregulation by gamma delta+ T cells. J Immunol 1996;156:232-7.
108. Emoto M, Miyamoto M, Emoto Y, Zerrahn J, Kaufmann SH. A critical role of T-cell receptor gamma/delta cells in antibacterial protection in mice early in life. Hepatology 2001;33:887-93.
109. Tseng CT, Miskovsky E, Houghton M, Klimpel GR. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 2001;33:1312-20.
110. Agrati C, D’offozo G, Narciso P et al. Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons. Mol Med 2001;7:11-19.
111. Leroy V, Vigan I, Mosnier JF et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003;38:829-41.
112. Deignan T, Curry MP, Doherty DG et al. Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol 2002;37:101-8.
113. Wisse E, van’t Noordende JM, van der Meulen J, Daems WT. The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 1976;173:423-35.
114. Hata K, Ru Zhang X, Iwatsuki S, Van Thiel D, Herberman R, Whiteside T. Isolation, phenotyping and functional analysis of lymphocytes from human liver. Clin Immunol Pathol 1990:56:401-19.
115. Hata K, Van Thiel D, Herberman RB, Whiteside T. Natural killer activity of human-derived lymphocytes in various liver diseases. Hepatology 1991;14:495-503.
116. Takii Y, Hashimoto S, Iiai T, Watanabe H, Hatakeyama K, Abo T. Increase in the proportion of granulated CD56+ T cells in patients with malignancy. Clin Exp Immunol 1994;97:522-7.
117. Winnock M, Garcia-Barcina M, Huet S et al. Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology 1993;105:1152-8.
118. Winnock M, Garcia-Barcina M, Bioulac-Sage, P Balabaud C. Liver-associated lymphocytes: role in tumor defense. Semin Liver Dis 1993;13:81-92.
119. Norris S, Doherty DG, Curry M et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother 2003;52:53-8.
120. Lanier LL, Corliss B, Philips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997;155:145-54.
121. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-62.
122. Godfrey DI, Hammond KJL, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-83.
123. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997;159:2240-9.
124. Park S, Benlagha K, Lee D, Balish E, Bendelac A. Unaltered phenotype, tissue distribution and function of Vα14+ NKT cells in germ-free mice. Eur J Immunol 2000;30:, 620-5.
125. Cui J, Shin T, Kawano T et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumours. Science 1997;278:1623-6.
126. Lamont AG, Adorini L. IL-12: a key cytokine in immune regulation. Immunol Today 1996;17:214-17.
127. Terabe M, Matsui S, Noben-Trauth N et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunol 2000;1:515-20.
128. + αβT cells activated by IL-12 as a major effector in inhibition of experimental tumour metastasis. J Immunol 1996;156:3366-73.
129. Kenna T, Golden Mason L, Porcelli S et al. NKT cells from normal and tumour-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 2003;171:1775-9.
130. Calne RY. Immunological tolerance - the liver effect. Immunol Rev 2000;174:280-2.
131. Bertolino P, McCaughan GW, Bowen DG. Role of primary intrahepatic T-cell activation in the ‘liver tolerance effect’. Immunol Cell Biol 2002;80:84-92.
132. Emoto M, Kaufmann S. Liver NKT cells: an account of heterogeneity. Trends Immunol 2003;24:364-9.
133. + T cells in T helper 1 immune responses. Immunol Rev 2000;174:35-46.
134. Ju C, McCoy JP, Chung CJ, Graf ML, Pohl LR. Tolerogenic role of Kupffer cells in allergic reactions. Chem Res Toxicol 2003;16:1514-19.
135. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003;198:39-50.
136. Sun Z, Wada T, Maemura K et al. Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl 2003;9:489-97.
137. Kelly AM, Golden-Mason L, McEntee G et al. Interleukin 12 (IL-12) is increased in tumour bearing human liver and expands CD8(+) and CD56(+) T cells in vitro but not in vivo. Cytokine 2004;25:273-82.
138. Khanna A, Morelli AE, Zhong C, Takayama T, Lu L, Thomson AW. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000;164:1346-54.
139. Exley MA, He Q, Cheng O et al. Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J Immunol 2002;168:1519-23.
140. Exley MA, Tahir SM, Cheng O et al. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol 2001;167:5531-4.
141. Branch Moody D, Young DC, Cheng TY et al. T cell activation by lipopeptide antigens. Science 2004;303:527-31.
142. Trobonjaca Z, Leithäuser F, Möller P, Schirmbeck R, Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-g release by liver NKT cells. J Immunol 2001;167:1413-22.
143. Grant AJ, Goddard S, Ahmed-Choudhury J et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol. 2002;160:1445-55.
144. Calne RY, Sells RA, Pena JR. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-6.
145. Kamada N, Brons G, Davies HS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980;29:429-31.
146. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-82.
147. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982;155:31-41.
148. Gruner NH, Lechner F, Jung MC et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-8.
149. Cooper S, Erickson AL, Adams EJ et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999;10:439-49.
150. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-406.
151. Iwakoshi NN, Goldschneider I, Tausche F, Mordes JP, Rossini AA, Greiner DL. High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone Bio-Breeding rats. J Immunol 1998;160:5838-50.
152. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-9.
153. Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D, Budd RC. Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens. J Exp Med 1998;188:1147-57.
154. Belz GT, Altman JD, Doherty PC. Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA 1998;95:13812-17.
155. Mehal WZ, Azzaroli F, Crispe IN. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001;167:667-73.
156. Iwakoshi NN, Greiner DL, Rossini AA, Mordes JP. Diabetes prone BB rats are severely deficient in natural killer T cells. Autoimmunity 1999;31:1-14.
157. John B, Crispe IN. Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 2004;172:5222-9.
158. Wang XZ, Stepp SE, Brehm MA, Chen HD, Selin LK, Welsh RM. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity 2003;18:631-42.